#lintonpharm

Collection of lintonpharm news, found 4 news.

LintonPharm to release data on Catumaxomab for advanced Gastric Cancer with peritoneal metastasis at 2022 ASCO Annual Meeting

LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging ...

LintonPharm announces first patient dosed in Phase 1 clinical trial of catumaxomab for Non-Muscle-Invasive Bladder Cancer unresponsive to Bacillus Calmette-Guerin

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...

LintonPharm announces authorization from China health authority (NMPA) to proceed with a phase 1/2 trial evaluating catumaxomab for the treatment of Non-Muscle Invasive Bladder Cancer

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...

LintonPharm announces authorization from China health authority to proceed with a global Phase 3 trial evaluating Catumaxomab in advanced gastric cancer

- LintonPharm Co. Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T-cell ...